HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term vitamin A supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa.

Abstract
Retinitis pigmentosa (RP) is caused by one of many possible gene mutations. The National Institutes of Health recommends high daily doses of vitamin A palmitate for RP patients. There is a critical knowledge gap surrounding the therapeutic applicability of vitamin A to patients with the different subtypes of the disease. Here, we present a case report of a patient with RP caused by a p.D190N mutation in Rhodopsin (RHO) associated with abnormally high quantitative autofluorescence values after long-term vitamin A supplementation. We investigated the effects of vitamin A treatment strategy on RP caused by the p.D190N mutation in RHO by exposing Rhodopsin p.D190N (RhoD190N/+) and wild-type (WT) mice to experimental vitamin A-supplemented and standard control diets. The patient's case suggests that the vitamin A treatment strategy should be further studied to determine its effect on RP caused by p.D190N mutation in RHO and other mutations. Our mouse experiments revealed that RhoD190N/+ mice on the vitamin A diet exhibited higher levels of autofluorescence and lipofuscin metabolites compared to WT mice on the same diet and isogenic controls on the standard control diet. Vitamin A supplementation diminished photoreceptor function in RhoD190N/+ mice while preserving cone response in WT mice. Our findings highlight the importance of more investigations into the efficacy of clinical treatments like vitamin A for patients with certain genetic subtypes of disease and of genotyping in the precision care of inherited retinal degenerations.
AuthorsXuan Cui, Hye Jin Kim, Chia-Hua Cheng, Laura A Jenny, Jose Ronaldo Lima de Carvalho, Ya-Ju Chang, Yang Kong, Chun-Wei Hsu, I-Wen Huang, Sara D Ragi, Chyuan-Sheng Lin, Xiaorong Li, Janet R Sparrow, Stephen H Tsang
JournalHuman molecular genetics (Hum Mol Genet) Vol. 31 Issue 14 Pg. 2438-2451 (07 21 2022) ISSN: 1460-2083 [Electronic] England
PMID35195241 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Vitamin A
  • Rhodopsin
Topics
  • Animals
  • Dietary Supplements
  • Mice
  • Mutation
  • Retinal Degeneration (genetics)
  • Retinitis Pigmentosa (drug therapy, genetics, metabolism)
  • Rhodopsin (genetics, metabolism)
  • Vitamin A

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: